Parenteral Drug Association
Connecting People, Science and Regulation ®
by: Christoph Bredack, PhD, Genedata
by: Lucia Ceresa
by: Parampal Deol
Particle Measuring Systems
Glenn E. Wright, PDA, Inc.
Michael Sadowski, Baxter Healthcare Corporation
PDA, Inc.
Hayden Skalski, Sievers Instruments
Co-Chairs Cristiana Campa, PhD, GSK and Raf De Dier, PhD, Janssen
Patrick Nieuwenhuizen, PharmaLex
Scott Lute, U.S. FDA, Josh Eaton, PDA, Inc., and Kurt Brorson, Parexel International
David Jaworski, PDA, Inc.
Jette Christensen, PhD, Immediate Past Chair
Ahmed Elsaid, Emergent BioSolutons, and Ajay Pazhayattil, Capcium Inc.
Mary Oates, PhD
Cristiana Campa, PhD, GSK; Michael R. DeFelippis, PhD, Eli Lilly; Raf De Dier, PhD, Janssen; and Anthony Cannon, MSD
Meg Gallwitz, Consultant
Ahmed Elsaid, Emergent BioSolutions, and Ajay Pazhayattil, Capcium Inc.
Tamer Helmy, PhD
Subrata Chakraborty, Gxpfont Consulting Group and Hal Baseman, ValSource, Inc.
Marilyn L. Foster, PDA
PDA Europe
Adam Caruso, Merck & Co.
Mike Jovanis, Vice President of Vault Quality at Veeva Systems
Claire Fritz Briglia, Vedere Solutions LLC, et al.
Bettine Boltres, West Pharmaceutical Services
Richard Johnson, PDA, Inc.
Kacey Pouliot, Pall Laboratory
Tony Cundell, PhD, Microbiological Consulting, LLC, and Associate Editor, PDA JPST
Michael Edey, Pfizer Inc. and Derek Duncan, Lighthouse Instruments
Kate Zabriskie, Business Training Works, Inc.
Susan Schniepp, PDA Chair 2022-2023
Marilyn L. Foster, PDA, Inc.
Russell E. Madsen, The Williamsburg Group
John Shabushnig, PhD, Insight Pharma Consulting LLC, and Romain Veillon, PharmD, GSK Vaccines
Bettine Boltres, PhD, West Pharmaceutical Services
Richard M. Johnson, PDA
Walter Morris, PDA Inc.
Ruby Gulati and Snehal Parikh, Roche-Genentech
Jette Christensen, PDA Chair 2020-2021
Jason V. Barger, Consultant
Anil Sawant, PhD, Merck & Co.
Walter Morris, PDA, Inc.
Rafael Beaus, PhD, Azbil Telstar, James N. Polarine, STERIS Corporation, and Benoit Ramond, PhD, Sanofi
Glenn Wright, PDA, Inc.
Trevor Swan, PDA
Subrata Chakraborty, GxPFONT Consulting Group
Denyse Baker, Jeff Broadfoot, Steve Mendivil, Adam Caruso, and Sandra Lueken
PDA New England Chapter
Julie C. Maurhoff, Ultragenyx Pharmaceutical and DI Workshop Planning Committee Member
Diana Patzelt, PhD, Claudia Scherwing, and Tricia Vail, Sartorius
Denyse Baker, AstraZeneca
Elizabeth Baker, JD, Zach Cockrum, Lawrence Niles, PhD, David Mizrahi, PhD, and Ryan Phelan representing member organizations of the Horseshoe Crab Recovery Coalition
Don Klein, PhD, DLK Consulting Services, Inc.
Tamer Helmy, PhD, Molecular Templates Inc.
Mary Oates, Emergent BioSolutions
G (Som) Somasundaram and Priyabrata Pattnaik, PhD, Merck Life Science
Bettine Boltres, West Pharmaceutical Services Deutschland GmbH & Co KG and Lee Leichter, P/L Biomedical
PDA Southern California Chapter
Bob Myers, PDA
Stephan Krause, Adele Chambers, Ryan Courtney, Darrin Cowley, and Anthony Mire-Sluis, AstraZeneca
Richard Johnson, PDA
Ray Roggero, Medvacon Life Sciences
Marilyn Foster, PDA, Inc.
Bettine Boltres, West Pharmaceutical Services Deutschland GmbH & Co KG
Richard M. Johnson, President, PDA Foundation
Klaus Wuchner, Janssen, et al.
PDA Letter
Task Force Co-Chairs Eva M. Urban, CSL Behring, and Tiffany Baker, ValSource, LLC
Brett Hoffmeister, Associates of Cape Cod, Inc., Allen Burgenson, Lonza, and John Dubczak, Charles River Laboratories
Richard Chai, STERIS Corporation, Priyabrata Pattnaik, Merck Pte. Ltd., and Bruce Loxley, GSK
John Ayres, MD, Pharma Safety Solutions, LLC and Rob Miller, MS, Pfizer Inc.
M. Amin Khan and Cristiana Campa, GSK
Tony Cundell, PhD, Microbiological Consulting, LLC and PDA COVID-19 Pandemic Task Force